Short-term activation of PERK alleviates the progression of experimental non-alcoholic steatohepatitis

被引：1
|
作者：
Fu, Wei [1 ,2 ,3 ,4 ]
Liu, Cenxi [1 ,2 ]
Li, Jin [1 ,2 ]
机构：
[1] Fudan Univ, State Key Lab Genet Engn, Shanghai, Peoples R China
[2] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China
[3] Henan Univ Sci & Technol, Affiliated Hosp 1, Henan Key Lab Rare Dis, Endocrinol & Metab Ctr, Luoyang, Peoples R China
[4] Henan Univ Sci & Technol, Coll Clin Med, Luoyang, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 79卷 / 06期
关键词：
D O I：
10.1016/j.jhep.2023.05.036
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E234 / E236
页数：3
相关论文
共 50 条
  • [31] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
    Roeb, Elke
    DRUG RESEARCH, 2021, 71 : S16 - S18
  • [32] High-Risk Groups for Non-alcoholic Fatty Liver and Non-alcoholic Steatohepatitis Development and Progression
    Yedidya Saiman
    Royce Hooks
    Rotonya M. Carr
    Current Hepatology Reports, 2020, 19 (4) : 412 - 419
  • [33] Treatment of alcoholic and non-alcoholic steatohepatitis
    Stremmel, W
    Blechacz, B
    Herrmann, T
    Rost, D
    Mueller, S
    INTERNIST, 2001, 42 (12): : 1641 - +
  • [34] Combined alcoholic and non-alcoholic steatohepatitis
    Wandji, Line Carolle Ntandja
    Gnemmi, Viviane
    Mathurin, Philippe
    Louvet, Alexandre
    JHEP REPORTS, 2020, 2 (03)
  • [35] Molecular mechanisms of fibrosis progression in non-alcoholic steatohepatitis (NASH)
    Hellerbrand, C.
    LIVER CIRRHOSIS: FROM PATHOPHYSIOLOGY TO DISEASE MANAGEMENT, 2008, 162 : 75 - +
  • [36] Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma
    Yasui, Kohichiroh
    Hashimoto, Etsuko
    Tokushige, Katsutoshi
    Koike, Kazuhiko
    Shima, Toshihide
    Kanbara, Yoshihiro
    Saibara, Toshiji
    Uto, Hirofumi
    Takami, Shiro
    Kawanaka, Miwa
    Komorizono, Yasuji
    Okanoue, Takeshi
    HEPATOLOGY RESEARCH, 2012, 42 (08) : 767 - 773
  • [37] Role of Fcgamma receptors in experimental Non-Alcoholic Steatohepatitis
    Cabrera, Daniel
    Jara, Evelyn
    Cruz, Ricardo
    Munoz-Durango, Natalia
    Rojas de Santiago, Pamela
    Kalergis, Alexis
    Arrese, Marco
    HEPATOLOGY, 2015, 62 : 686A - 686A
  • [38] Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
    Shu, Xiangbing
    Li, Meng
    Cao, Ying
    Li, Chunlin
    Zhou, Wenjun
    Ji, Guang
    Zhang, Li
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [39] Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
    Cabrera, Daniel
    Wree, Alexander
    Povero, Davide
    Sols, Nancy
    Hernandez, Alejandra
    Pizarro, Margarita
    Moshage, Han
    Torres, Javiera
    Feldstein, Ariel E.
    Cabello-Verrugio, Claudio
    Brandan, Enrique
    Barrera, Francisco
    Pablo Arab, Juan
    Arrese, Marco
    SCIENTIFIC REPORTS, 2017, 7
  • [40] Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
    Daniel Cabrera
    Alexander Wree
    Davide Povero
    Nancy Solís
    Alejandra Hernandez
    Margarita Pizarro
    Han Moshage
    Javiera Torres
    Ariel E. Feldstein
    Claudio Cabello-Verrugio
    Enrique Brandan
    Francisco Barrera
    Juan Pablo Arab
    Marco Arrese
    Scientific Reports, 7
12345